Emerging Stocks Down Under 2 November 2020: Aroa Biosurgery, Alcidion Group, Elsight

Emerging Stocks Down Under Edition #7

Aroa Biosurgery: Valuable sheep guts

In today’s edition of Emerging Stocks Down Under, Auckland-based biotechnology company Aroa Biosurgery had a great start to its listed life on ASX in July 2020. The company offered 60 million shares at A$0.75 per share in its IPO, but the stock came on the boards at $1.40 and has yet to go below $1.25. Investors have liked Aroa because this company is now revenue-stage and because its products, designed to improve healing in complex wounds and soft tissue reconstruction, are demonstrably superior to the competition’s.

Also in today’s edition, a look at hospital management software developer the Alcidion Group (ASX: ALC) and communication and network security company Elsight (ASX: ELS).

Get access to all editions through a 2-week FREE TRIAL. No charge on sign up.

Click here to read the previous edition of Emerging Stocks Down Under published 27 October 2020

For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter